Prudential Financial’s Niagen Bioscience, Inc. Common Stock NAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.93M | Buy |
133,846
+38,461
| +40% | +$554K | ﹤0.01% | 1401 |
|
|
2025
Q1 | $658K | Buy |
95,385
+16,170
| +20% | +$112K | ﹤0.01% | 1730 |
|
|
2024
Q4 | $420K | Buy |
79,215
+56,400
| +247% | +$299K | ﹤0.01% | 1893 |
|
|
2024
Q3 | $83.3K | Hold |
22,815
| – | – | ﹤0.01% | 2596 |
|
|
2024
Q2 | $62.3K | Sell |
22,815
-2,985
| -12% | -$8.15K | ﹤0.01% | 2593 |
|
|
2024
Q1 | $89.8K | Hold |
25,800
| – | – | ﹤0.01% | 2537 |
|
|
2023
Q4 | $36.9K | Hold |
25,800
| – | – | ﹤0.01% | 2577 |
|
|
2023
Q3 | $37.7K | Hold |
25,800
| – | – | ﹤0.01% | 2529 |
|
|
2023
Q2 | $40.5K | Buy |
+25,800
| New | +$40.5K | ﹤0.01% | 2553 |
|
|
2020
Q4 | – | Sell |
-29,000
| Closed | -$116K | – | 2511 |
|
|
2020
Q3 | $116K | Buy |
+29,000
| New | +$116K | ﹤0.01% | 2358 |
|